Difference between revisions of "Part:BBa K4165224"
Line 5: | Line 5: | ||
6 aa flexible linker with G and S Residues | 6 aa flexible linker with G and S Residues | ||
− | + | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | A flexible linker with G and S aa residues with variable lengths. According to our project, 3 flexible linker required one for our clamps for binding of Tau or amyloid beta with our binding paptides . Second one for flexible linking between clamps and HTRA1 binding peptide . last one for binding our HTRA1 binding peptide with PDZ domain of our protease HTRA1. our linker with length [6 aa GGSGGG ] was calculated by our team for testing how it would affect interaction of our mentioned parts with each other using Pymol Software. | ||
<!-- --> | <!-- --> | ||
Line 12: | Line 13: | ||
<partinfo>BBa_K4165224 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4165224 SequenceAndFeatures</partinfo> | ||
+ | ===References=== | ||
+ | |||
+ | 1- Yuan, S., Chan, H. S., & Hu, Z. (2017). Using pymol as a platform for computational drug design. WIREs Computational Molecular Science, 7(2). doi:10.1002/wcms.1298 | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display |
Revision as of 07:47, 8 October 2022
GGSGGG Linker
6 aa flexible linker with G and S Residues
Usage and Biology
A flexible linker with G and S aa residues with variable lengths. According to our project, 3 flexible linker required one for our clamps for binding of Tau or amyloid beta with our binding paptides . Second one for flexible linking between clamps and HTRA1 binding peptide . last one for binding our HTRA1 binding peptide with PDZ domain of our protease HTRA1. our linker with length [6 aa GGSGGG ] was calculated by our team for testing how it would affect interaction of our mentioned parts with each other using Pymol Software.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
References
1- Yuan, S., Chan, H. S., & Hu, Z. (2017). Using pymol as a platform for computational drug design. WIREs Computational Molecular Science, 7(2). doi:10.1002/wcms.1298